Severe malaria with encephalopathy and acute kidney failure

Authors

  • André Miranda Baptista Instituto de Infectologia Emílio Ribas, São Paulo - SP - Brasil.
  • Camilla Marjorie Ribeiro Sanguin Instituto de Infectologia Emílio Ribas, São Paulo - SP - Brasil.
  • Guilherme Spaziani Maria Instituto de Infectologia Emílio Ribas, São Paulo - SP - Brasil.
  • Marcos Vinicius da Silva Instituto de Infectologia Emílio Ribas, São Paulo - SP - Brasil.

DOI:

https://doi.org/10.5935/2764-734X.e202204013

Keywords:

Malaria, Acute kidney injury, Acute febrile encephalopathy, Time-to-treatment, Case Report

Abstract

The Legal Amazon region concentrates 99% of malaria cases in Brazil, where Plasmodium vivax is the main etiological agent (90% of cases). This report aims to demonstrate the main role of the patient’s epidemiological history in an acute febrile jaundice syndrome - it’s a case of malaria diagnosed in a patient coming from Benin, Africa, where all cases correspond to Plasmodium falciparum infection. The diagnosis and introduction of appropriate treatment with artesunate were delayed, in such a way that the patient progressed to severe forms of the disease (acute kidney injury and encephalopathy), followed by death.

References

1. World Health Organitazion (WHO). World malaria report 2019 [Internet]. Geneva: WHO; 2019. [acesso em 2021 Set 05]. Disponível em: https://www.who.int/publications/i/item/9789241565721

2. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Guia prático de tratamento da malária no Brasil. Brasília (DF): Ministério da Saúde; 2020. [acesso em 2021 Set 05]. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/guia_tratamento_malaria_brasil.pdf

3. Ministério da Saúde (BR). Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Manual de vigilância, prevenção e controle de zoonoses. Brasília (DF): Ministério da Saúde; 2016. [acesso em 2021 Set 05]. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/publicacoes-svs/zoonose/manual-zoonoses-normas-2v-7julho16-site.pdf/view

4. Ministério da Saúde (BR). DATASUS - Indicadores de dados básicos Brasil: índice parasitário anual (IPA) de malária [Internet]. Brasília (DF): Ministério da Saúde; 2021; [acesso em 2020 Set 07]. Disponível em: http://tabnet.datasus.gov.br/cgi/idb2000/fqd04.htm#:~:text=Esse%20risco%20est%C3%A1%20relacionado%20%C3%A0,(%E2%89%A550%2C0)

5. Koopmans L, Wolfswinkel M, Hesselink, D, Hoorn E, Koelewijn R, Van Hellemond JJ, et al. Acute kidney injury in imported Plasmodium falciparum malaria. Malaria J. 2015;14:523. doi: 10.1186/s12936-015-1057-9.

6. Nguansangiam S, Day NPJ, Hien TT, Mai NTH, Chaisri U, Riganti M, et al. A quantitative ultrastructural study of renal pathology in fatal Plasmodium falciparum malaria. Trop Med Int Health. 2007 Set;12(9):1037-50.

7. Mishra SK, Das BS. Malaria and acute kidney injury. Semin Nephrol. 2008 Jul;28(4):395-408.

8. Plewes K, Royakkers AA, Hanson J, Hasan MMU, Alam S, Ghose A, et al. Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria. Malaria J. 2014 Mar;13:91. doi: 10.1186/1475-2875-13-91.

9. Mishra SK, Newton CRJC. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol. 2009 Abr;5(4):189-98.

10. Queiroz NL, Teixeira MM, Teixeira AL. Imunopatogênese da malaria cerebral. Rev Bras Neurol. 2008;44(1):13-9.

11. World Health Organitazion (WHO). Severe malaria. Trop Med Int Health. 2014 Set;19(Supl 1):S7-S131. doi: 10.1111/tmi.12313_2.

Downloads

Additional Files

Published

2022-07-27

How to Cite

Baptista, A. M., Sanguin, C. M. R., Maria, G. S., & Silva, M. V. da. (2022). Severe malaria with encephalopathy and acute kidney failure. Infections in Evidence, 1, e202204013. https://doi.org/10.5935/2764-734X.e202204013

Issue

Vol. 1 (2022)

Section

Case Reports

License

Copyright (c) 2022 Infections in Evidence

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Copyright Transfer Agreement assumes that the authors are the legitimate holders of the copyright of the Case Report in question, without infringing any copyright, trademark or patent of others. In this way, they transfer all rights to this manuscript or any revision, version or translation of it to the Journal, including here the exclusivity of its eventual commercialization, provided that in accordance with ethical and moral precepts and relevant Brazilian legislation. All articles in the INFECTIONS IN EVIDENCE Journal are published under the terms of international license 4.0 of the Creative Commons Attribution, which allows users to freely read, download, share and adapt cultural and scientific productions, provided that due credit is given to the original authors and publication.
The Copyright Transfer Agreement also understands that the authors guarantee that the respective Case Report has never been published in another communication vehicle or scientific journal. Papers presented at meetings and/or scientific congresses may be published in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided that they have not been published in whole or in part in their Proceedings or Annals.